To further development of our gene expression approach to chemotherapy resistance, we have employed whole genome microarray expression profiling as a discovery platform to identify genes implicated in
Common molecular biomarkers were identified in different key cellular processes at different timepoints for the drugs of the high-responsive group. Benjamini-Hochberg corrected p-values p were calcula